This is a list of all Pulmonology related medical scores and algorithms with their corresponding calculator/app.
Estimates the VO2 max aerobic capacity through the four most common methods from resting heart rate to activity tests.
Determines the predicted maximum speed of expiration based on age, gender and height and compares it to the measured PEFR.
Determines the target tidal volume by height and depth of ETT placement.
Determines vascular resistance based on pressure difference and blood flow in pulmonary circulation.
Determines the mean airway pressure applied during positive-pressure mechanical ventilation.
Helps with the differential diagnosis between pleural effusions of exudate and transudate type.
Determines the total volume of gas in or out of the lung per minute based on tidal volume and respiratory rate.
Determines the ratio of the forced expiratory volume in the first second to the forced vital capacity of the lungs.
Uses lung volumes to determine vital, inspiratory and functional residual capacity.
Determines the total volume of fresh air entering the alveoli per minute.
Stratifies pulmonary embolism (PE) mortality risk based on clinical data.
Assesses if successful extubation is possible in intubated patients breathing spontaneously who meet other clinical criteria.
Determines the partial pressure of alveolar oxygen that reflects the ventilation process.
Estimates the pulmonary VC based on tidal, inspiratory and expiratory reserve volumes.
Predicts survival in patients with chronic obstructive pulmonary disease (COPD).
Determines arterial oxygen based on haemoglobin, O2 saturation and arterial pressure.
Evaluates cases of severe acute respiratory failure to check the need for extracorporeal membrane oxygenation (EMCO) instead of ventilation.
Determines MPAP which is used to check for pulmonary hypertension.
Assesses the severity of apnea, therefore can help clinicians with the diagnosis of obstructive sleep apnea.
Predicts postoperative risk of PRF in elderly male patients based on available clinical data and type of surgery.
Determines the air that remains in the lungs after maximal expiration.
Determines the expected distance to be walked when evaluating the patient’s functional status in cardiopulmonary conditions.
Corrects the pulmonary result for haemoglobin in patients with anemia.
Determines the PaO2/FiO2 ratio which assesses lung function in acute respiratory distress.
Provides an alternative way to estimate vital capacity based on gender, age and height when inspiratory, tidal and expiratory volumes can’t be measured.
Determines the resistance of the respiratory tract to airflow during inhalation and exhalation.
Determines the most commonly tested respiratory parameters and capacities based on easily obtained data and volumes.
Diagnoses community acquired pneumonia and stratifies mortality risk.
Helps diagnose streptococcal pharyingitis in children and adults based on clinical data.
Estimates the IC based on the inspiratory reserve and the tidal volume.
Stratifies patients according to their chances of being diagnosed with ventilator associated pneumonia.
Stratifies pulmonary embolism risk before invasive testing or CT angiography take place.
Screens for obstructive sleep apnea based on symptoms and OSA risk factors.
Predicts outcomes in patients with acute lung injury and acute respiratory distress syndrome, and helps determine need for ECMO.
Determines the amount of oxygen delivered to the capillaries per minute based on arterial oxygen content and cardiac output.
Helps diagnose hypoxemia and its cause based on the difference between alveolar and arterial oxygen concentration.
Estimates FRC based on expiratory reserve and residual volume.
Differentiates between patients at low or high risk of pulmonary embolism.
Diagnoses and evaluates ARDS severity based on required criteria and risk factors.
Predicts risk of pulmonary complications after surgery to help guide clinician decision making.
Consists of the original, revised and simplified Geneva risk predictors for pulmonary embolism (PE).
Evaluates the severity of dyspnea in patients who suffer from chronic obstructive pulmonary disease.
Stratifies patients with community acquired pneumonia and offers 30-day mortality prediction.
Determines bleeding risk in patients diagnosed with pulmonary embolism before anticoagulation therapy is initiated.
Helps diagnose FES based on Schonfeld rule and Gurd's and Wilson's criteria.
Predicts likelihood of cancer of the evaluated lung nodules in the next 2 to 4 years.
Determines the amount of physiological dead space in a person's lungs to evaluate extent of wasted ventilation.
Predicts 2-year survival rates for patients with small cell lung cancer (SCLC) based on Karnofsky score and lab tests.
Prognoses likelihood of future acute asthma in pediatric patients.
Evaluates risk of asthma diagnosis in the future for children aged three or less suffering from recurrent wheezing.
Evaluates respiratory health and whether the patient suffers from symptoms and signs of asthma.
Predicts 30-day mortality risk in patients with active cancer diagnosed with PE.
Stratifies pulmonary disease based on FEV1, FVC results and dyspnea severity.
Helps predict risk of mechanical ventilation for longer than 48 hours or risk of reintubation within 30 days from surgery.
Helps screen patients at increased risk of postoperative pneumonia based on available clinical data.
